Bebtelovimab 175 mg
This code is not in the latest file (4Q26). It was last listed in 2Q23.
Payment limit per 175 MG, by effective quarter, 4Q22 to 2Q23. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under Q0222
No NDCs mapped to this code in the 4Q26 crosswalk.
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 2Q23 | $2,394.00 | $0.00 | 175 MG | Bebtelovimab 175 mg | v1, posted February 23, 2024 |
| 1Q23 | $2,394.00 | $0.00 | 175 MG | Bebtelovimab 175 mg | v1, posted December 6, 2023 |
| 4Q22 | $2,394.00 | – | 175 MG | Bebtelovimab 175 mg | v1, posted June 22, 2023 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 2Q23: 2024-02-23_april-2023-asp-pricing-file.zipposted February 23, 2024
- 1Q23: 2023-12-06_january-2023-asp-pricing-file.zipposted December 6, 2023
- 4Q22: 2023-06-22_october-2022-asp-pricing-file.zipposted June 22, 2023